Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
Tài liệu tham khảo
Williams
ten Hoedt
Burton
Vockley
Moyle
Pietz
Smith, 2000, Behaviour in early treated phenylketonuria: a systematic review, Eur J Pediatr, 159, S89, 10.1007/PL00014392
Gassio
Weglage
Blau
Jahja
DeRoche, 2008, Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function, Dev Neuropsychol, 33, 474, 10.1080/87565640802101482
Bilder
Palermo
Romani
van Wegberg
van Spronsen
Brown, 2016, Phenylketonuria (PKU): a problem solved?, Mol Genet Metab Rep, 6, 8, 10.1016/j.ymgmr.2015.12.004
Bik-Multanowski, 2008, Quality of life in noncompliant adults with phenylketonuria after resumption of the diet, J Inherit Metab Dis, 31, S415, 10.1007/s10545-008-0978-7
Longo
Palynziq. [prescribing information]. Novato, CA: BioMarin Pharmaceutical Inc.; 2018.
Thomas
Harding
Brouwers
Brouwers
Singh
Moher
Schardt
Oxford Centre for Evidence-Based Medicine. Levels of evidence (March 2009). https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed March 2018.
Woolf
National Institutes of Health Office of Dietary Supplements. Nutrient recommendations: Dietary Reference Intakes (DRI). https://ods.od.nih.gov/Health_Information/Dietary_Reference:Intakes.aspx. Accessed April 2018.
Zori
Longo N, Zori R, Wasserstein MP, et al. Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined Phase 2 outcomes through PAL-003 extension study. Orphanet J Rare Dis. 2018 Jul 4;13:108. https://doi.org/10.1186/s13023-018-0858-7.
Committee opinion no. 636: management of women with phenylketonuria. Obstet Gynecol. 2015;125:1548-1550.
Zeile
Kruger
Costello
Cox, 2006, Treating self-injection phobia in patients prescribed injectable medications: a case example illustrating a six-session treatment model, Cogn Behav Pract, 11, 278, 10.1016/S1077-7229(04)80042-7
Hanley
Pode-Shakked
Donati
Cohn
Samycia, 2016, Experiences from a combined dermatology and rheumatology clinic: a retrospective review, J Cutan Med Surg, 20, 486, 10.1177/1203475416649138
Guo
Park
Abdel Fattah
Jin
Karashima, 2012, Oral zinc therapy for zinc deficiency-related telogen effluvium, Dermatol Ther, 25, 210, 10.1111/j.1529-8019.2012.01443.x
Slonim
Moeinvaziri, 2009, Iron status in diffuse telogen hair loss among women, Acta Dermatovenerol Croat, 17, 279
Park
Amor, 2010, Does D matter? The role of vitamin D in hair disorders and hair follicle cycling, Dermatol Online J, 16, 3, 10.5070/D38S34P6B7
Rasheed
Ghafoor, 2017, Vitamin D deficiency in alopecia areata, J Coll Physicians Surg Pak, 27, 200
Mahamid, 2014, Association between vitamin D levels and alopecia areata, Isr Med Assoc J, 16, 367
Sengupta
Wolf B. Biotinidase deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al. GeneReviews. Seattle (WA): University of Washington, 2016. https://www.ncbi.nlm.nih.gov/books/NBK1322/ Accessed December 2018.
Fujimoto, 2005, Biotin deficiency in an infant fed with amino acid formula, J Dermatol, 32, 256, 10.1111/j.1346-8138.2005.tb00758.x
Bradfield
McLaren
Mazzocco
Pietz
Webster D, Wildgoose J Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev. 2013;6:CD001507.
Smith
Hase
Lou
Lykkelund
Kalsner
Yano
van Spronsen, 2001, Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets, Am J Clin Nutr, 73, 153, 10.1093/ajcn/73.2.153
Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance. J Am Diet Assoc. 2000;100:1543-1556.
Kniskern
American Dietetic Association, Dietitians of Canada., 2003, Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets, Can J Diet Pract Res, 64, 62, 10.3148/64.2.2003.62
Evans
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology., 2010, Drug allergy: an updated practice parameter, Ann Allergy Asthma Immunol, 105, 259, 10.1016/j.anai.2010.08.002
Lichtenstein
Swierczewska
Stidl
Turecek
Hasson
Lubich
Ivens
Webster
Konkle
Abbott, 2015, Allergic reactions associated with intravenous versus intramuscular pegaspargase: a retrospective chart review, Paediatr Drugs, 17, 315, 10.1007/s40272-015-0129-1
Meller
Lubbe
Basaranoglu, 2006, Case study on drug-related adverse effects of hepatitis C therapy, Adv Ther, 23, 769, 10.1007/BF02850316
Henriksen
Wenande
Bernardeschi
Degen, 2013, Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial), J Dtsch Dermatol Ges, 11, 846
Kim
Hayat, 2011, Study for frequency and aetiology of lymphadenopathy during combination therapy for chronic hepatitis C (pegylated interferon alpha plus ribavirin) at a tertiary care hospital in Hyderabad, J Pak Med Assoc, 61, 986
Wilhelmi, 2006, Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease?, Swiss Med Wkly, 136, 65
Bielory
Lawley
Bashshur
Ribas, 2010, Agreement between dermatological diagnoses made by live examination compared to analysis of digital images, An Bras Dermatol, 85, 441, 10.1590/S0365-05962010000400004
Lepe, 2004, [First study of teledermatology in Mexico. A new public health tool], Gac Med Mex, 140, 23
Hailey, 2002, Systematic review of evidence for the benefits of telemedicine, J Telemed Telecare, 8, 1
Vyas
Simonaro
Fruhauf
Shapiro, 2004, Comparison of skin biopsy triage decisions in 49 patients with pigmented lesions and skin neoplasms: store-and-forward teledermatology vs. face-to-face dermatology, Arch Dermatol, 140, 525, 10.1001/archderm.140.5.525
Choquette, 2010, Reduced incidence of infusion reactions to infliximab in patients pre-medicated with acetaminophen, J Rheumatol, 37, 1324
Zidan, 2008, Oral premedication for the prevention of hypersensitivity reactions to paclitaxel, Med Oncol, 25, 274, 10.1007/s12032-007-9030-2
Sasada
Raisch
Quock
Peereboom
Kidera
Sudarshan
Navo
Kimura
Brockow
Mervak, 2015, Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT, AJR Am J Roentgenol, 205, 77, 10.2214/AJR.14.13810
Kim, 2011, Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea, Eur J Radiol, 80, 363, 10.1016/j.ejrad.2010.06.014
Bae
Trautmann, 2016, H1-antihistamine premedication in NSAID-associated urticaria, J Allergy Clin Immunol Pract, 4, 1205, 10.1016/j.jaip.2016.05.018
Mach
Bartoli, 2016, Premedication prevents infusion reactions and improves retention rate during infliximab treatment, Clin Rheumatol, 35, 2841, 10.1007/s10067-016-3351-5
Aeschlimann
Jacobstein, 2005, Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium, Inflamm Bowel Dis, 11, 442, 10.1097/01.MIB.0000158166.88238.ea
Sampson, 2006, Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol, 117, 391, 10.1016/j.jaci.2005.12.1303
Brown, 2004, Clinical features and severity grading of anaphylaxis, J Allergy Clin Immunol, 114, 371, 10.1016/j.jaci.2004.04.029
Scherer
Fajt
Poreaux
Akbayram, 2010, A desensitization protocol in children with L-asparaginase hypersensitivity, J Pediatr Hematol Oncol, 32, e187, 10.1097/MPH.0b013e3181e003c7
Shah
Taffet
Amoros-Reboredo
Mates, 2006, Desensitization to hydroxychloroquine—experience of4 patients, J Rheumatol, 33, 814
Fam
Galvao, 2015, Hypersensitivity to biological agents—updated diagnosis, management, and treatment, J Allergy Clin Immunol Pract, 3, 175, 10.1016/j.jaip.2014.12.006
Cernadas
Tucker, 2005, Digital imaging: a diagnostic screening tool?, Int J Dermatol, 44, 479, 10.1111/j.1365-4632.2005.01990.x
AGREE II workshop participants for the RARE-Bestpractices Consortium., 2015, Report of an international workshop to explore the utility of the AGREE II instrument for appraisal of rare disease guidelines, Rare Dis Orphan Drugs, 2, 11
Pai